Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma

Cancer Causes and Control

Volumn 20, Issue 1, 2009, Pages 47-55

  Lurie, Galina ^a   Wilkens, Lynne R ^a   Thompson, Pamela J ^a   McDuffie, Katharine E ^a   Carney, Michael E ^b   Terada, Keith Y ^b   Goodman, Marc T ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Case control study; Epithelial ovarian cancer; ESR2; Single nucleotide polymorphisms

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ESTROGEN RECEPTOR BETA; GESTAGEN;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONAL THERAPY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 58249121916     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9216-8     Document Type: Article

References (50)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L (2002) Cancer incidence in five continents. IARC, Lyon, France
2. SP Langdon GL Hirst EP Miller 1994 The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines J Steroid Biochem Mol Biol 50 131 135 10.1016/0960-0760(94)90019-1
3. F Galtier-Dereure F Capony T Maudelonde H Rochefort 1992 Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1 J Clin Endocrinol Metab 75 1497 1502 10.1210/jc.75.6.1497
4. T Riman S Nilsson IR Persson 2004 Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies Acta Obstet Gynecol Scand 83 783 795 10.1111/j.0001-6349.2004. 00550.x
5. HA Risch 1998 Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J Natl Cancer Inst 90 1774 1786 10.1093/jnci/90.23.1774
6. E Enmark JA Gustafsson 1999 Oestrogen receptors-an overview J Intern Med 246 133 138 10.1046/j.1365-2796.1999.00545.x
7. SG Hillier RA Anderson AR Williams M Tetsuka 1998 Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells Mol Hum Reprod 4 811 815 10.1093/molehr/4.8.811
8. M Byers GG Kuiper JA Gustafsson OK Park-Sarge 1997 Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins Mol Endocrinol 11 172 182 10.1210/me.11.2.172
9. T Rutherford WD Brown E Sapi S Aschkenazi A Munoz G Mor 2000 Absence of estrogen receptor-beta expression in metastatic ovarian cancer Obstet Gynecol 96 417 421 10.1016/S0029-7844(00)00917-0
10. AW Brandenberger MK Tee RB Jaffe 1998 Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues J Clin Endocrinol Metab 83 1025 1028 10.1210/jc.83.3.1025
11. P Pujol JM Rey P Nirde 1998 Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis Cancer Res 58 5367 5373
12. AJ Li RL Baldwin BY Karlan 2003 Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures Am J Obstet Gynecol 189 22 27 10.1067/mob.2003.328
13. A Bardin P Hoffmann N Boulle 2004 Involvement of estrogen receptor beta in ovarian carcinogenesis Cancer Res 64 5861 5869 10.1158/0008-5472.CAN-04-0552
14. BW Park KS Kim MK Heo 2003 Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis? Breast Cancer Res Treat 80 79 85 10.1023/A:1024406223619
15. T Fixemer K Remberger H Bonkhoff 2003 Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma Prostate 54 79 87 10.1002/pros.10171
16. EF Foley AA Jazaeri MA Shupnik O Jazaeri LW Rice 2000 Selective loss of estrogen receptor beta in malignant human colon Cancer Res 60 245 248
17. KH Tung MT Goodman AH Wu 2004 Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives Am J Epidemiol 159 750 758 10.1093/aje/kwh103
18. MR Sowers ML Jannausch DS McConnell SR Kardia JF Randolph Jr 2006 Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes Am J Med 119 S31 S43 10.1016/j.amjmed.2006.07.004
19. I Peter AM Shearman RS Vasan 2005 Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women Am J Hypertens 18 1388 1395 10.1016/j.amjhyper.2005.05.023
20. YH Sun B Yang XH Wang 2005 Association between single-nucleotide polymorphisms in estrogen receptor beta gene and risk of prostate cancer Zhonghua Wai Ke Za Zhi 43 948 951
21. KM Rexrode PM Ridker HH Hegener JE Buring JE Manson RY Zee 2007 Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women Clin Chem 53 1749 1756 10.1373/clinchem.2007.091454
22. Anonymous (1986) Surveillance, epidemiology, and end results program. Summary staging guide for the cancer surveillance, epidemiology, and end results reporting (SEER) Program. U.S. Department of Health and Human Services, Public Health Services, National Institute of Health, Bethesda, MD
23. Oyama N, Johnson DB (1986) Hawaii health surveillance program survey methods and procedures. R & S Report No 54. State Department of Health Research and Statistics Office, Honolulu, Hawaii
24. KH Tung MT Goodman AH Wu 2003 Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study Am J Epidemiol 158 629 638 10.1093/aje/kwg177
25. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 10.1093/bioinformatics/bth457
26. YC Chen P Kraft P Bretsky 2007 Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium Cancer Epidemiol Biomarkers Prev 16 1973 1981 10.1158/1055-9965.EPI-07-0431
27. DG Cox P Bretsky P Kraft 2008 Haplotypes of the estrogen receptor beta gene and breast cancer risk Int J Cancer 122 387 392 10.1002/ijc.23127
28. CL Pearce AM Near JL Butler 2008 Comprehensive evaluation of ESR2 variation and ovarian cancer risk Cancer Epidemiol Biomarkers Prev 17 393 396 10.1158/1055-9965.EPI-07-2512
29. K Yaffe K Lindquist S Sen 2007 Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study Neurobiol Aging 10.1016/j.neurobiolaging.2007.08.003 Available online 21 September 2007
30. A Bardin N Boulle G Lazennec F Vignon P Pujol 2004 Loss of ERbeta expression as a common step in estrogen-dependent tumor progression Endocr Relat Cancer 11 537 551 10.1677/erc.1.00800
31. J Cheng EJ Lee LD Madison G Lazennec 2004 Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis FEBS Lett 566 169 172 10.1016/j.febslet.2004.04.025
32. GG Kuiper E Enmark M Pelto-Huikko S Nilsson JA Gustafsson 1996 Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 5925 5930 10.1073/pnas.93.12.5925
33. P Roger ME Sahla S Makela JA Gustafsson P Baldet H Rochefort 2001 Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors Cancer Res 61 2537 2541
34. M Campbell-Thompson IJ Lynch B Bhardwaj 2001 Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer Cancer Res 61 632 640
35. E Sapi WD Brown S Aschkenazi 2002 Regulation of Fas ligand expression by estrogen in normal ovary J Soc Gynecol Investig 9 243 250 10.1016/S1071-5576(02) 00162-4
36. O Treeck G Pfeiler D Mitter C Lattrich G Piendl O Ortmann 2007 Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells J Endocrinol 193 421 433 10.1677/JOE-07-0087
37. JA Vendrell F Magnino E Danis 2004 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation J Mol Endocrinol 32 397 414 10.1677/jme.0.0320397
38. LC Li CC Yeh D Nojima R Dahiya 2000 Cloning and characterization of human estrogen receptor beta promoter Biochem Biophys Res Commun 275 682 689 10.1006/bbrc.2000.3363
39. YF Hu B Luscher A Admon N Mermod R Tjian 1990 Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity Genes Dev 4 1741 1752 10.1101/gad.4.10.1741
40. DP McDonnell 2005 The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer Clin Cancer Res 11 871s 877s
41. ET Alarid N Bakopoulos N Solodin 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation Mol Endocrinol 13 1522 1534 10.1210/me.13.9.1522
42. BR Bhavnani SP Tam X Lu 2008 Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors ER{alpha} and ER{beta} Endocrinology 10.1210/en.2008-0304
43. GG Kuiper B Carlsson K Grandien 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 863 870 10.1210/en.138.3.863
44. GG Kuiper JG Lemmen B Carlsson 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 4252 4263 10.1210/en.139.10.4252
45. HA Harris AR Bapat DS Gonder DE Frail 2002 The ligand binding profiles of estrogen receptors alpha and beta are species dependent Steroids 67 379 384 10.1016/S0039-128X(01)00194-5
46. BS Katzenellenbogen MM Montano TR Ediger 2000 Estrogen receptors: selective ligands, partners, and distinctive pharmacology Recent Prog Horm Res 55 163 193
47. V Beral D Bull J Green G Reeves 2007 Ovarian cancer and hormone replacement therapy in the Million Women Study Lancet 369 1703 1710 10.1016/S0140-6736(07)60534-0
48. AS Sit F Modugno JL Weissfeld SL Berga RB Ness 2002 Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma Gynecol Oncol 86 118 123 10.1006/gyno.2002.6746
49. MC Pike CL Pearce R Peters W Cozen P Wan AH Wu 2004 Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study Fertil Steril 82 186 195
50. MA Rossing KL Cushing-Haugen KG Wicklund JA Doherty NS Weiss 2007 Menopausal hormone therapy and risk of epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 16 2548 2556 10.1158/1055-9965.EPI-07-0550